Bio-Rad Laboratories Total Long-Term Assets 2010-2024 | BIO

Bio-Rad Laboratories total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Bio-Rad Laboratories total long-term assets for the quarter ending December 31, 2024 were $6.334B, a 31.53% decline year-over-year.
  • Bio-Rad Laboratories total long-term assets for 2024 were $6.334B, a 31.53% decline from 2023.
  • Bio-Rad Laboratories total long-term assets for 2023 were $9.251B, a 10.57% decline from 2022.
  • Bio-Rad Laboratories total long-term assets for 2022 were $10.344B, a 34.57% decline from 2021.
Bio-Rad Laboratories Annual Total Long-Term Assets
(Millions of US $)
2024 $6,334
2023 $9,251
2022 $10,344
2021 $15,809
2020 $10,833
2019 $5,829
2018 $3,588
2017 $2,296
2016 $2,006
2015 $1,932
2014 $1,625
2013 $1,631
2012 $1,507
2011 $1,299
2010 $1,087
2009 $973
Bio-Rad Laboratories Quarterly Total Long-Term Assets
(Millions of US $)
2024-12-31 $6,334
2024-09-30 $7,548
2024-06-30 $6,632
2024-03-31 $9,549
2023-12-31 $9,251
2023-09-30 $8,749
2023-06-30 $8,839
2023-03-31 $10,390
2022-12-31 $10,344
2022-09-30 $8,918
2022-06-30 $9,432
2022-03-31 $11,070
2021-12-31 $15,809
2021-09-30 $17,487
2021-06-30 $12,828
2021-03-31 $11,758
2020-12-31 $10,833
2020-09-30 $9,697
2020-06-30 $7,965
2020-03-31 $6,602
2019-12-31 $5,829
2019-09-30 $5,129
2019-06-30 $5,559
2019-03-31 $4,831
2018-12-31 $3,588
2018-09-30 $4,684
2018-06-30 $4,394
2018-03-31 $4,238
2017-12-31 $2,296
2017-09-30 $2,293
2017-06-30 $2,317
2017-03-31 $2,220
2016-12-31 $2,006
2016-09-30 $2,170
2016-06-30 $2,069
2016-03-31 $1,978
2015-12-31 $1,932
2015-09-30 $1,872
2015-06-30 $1,783
2015-03-31 $1,624
2014-12-31 $1,625
2014-09-30 $1,622
2014-06-30 $1,700
2014-03-31 $1,675
2013-12-31 $1,631
2013-09-30 $1,606
2013-06-30 $1,580
2013-03-31 $1,592
2012-12-31 $1,507
2012-09-30 $1,458
2012-06-30 $1,358
2012-03-31 $1,370
2011-12-31 $1,299
2011-09-30 $1,092
2011-06-30 $1,155
2011-03-31 $1,111
2010-12-31 $1,087
2010-09-30 $1,030
2010-06-30 $971
2010-03-31 $1,004
2009-12-31 $973
2009-09-30 $975
2009-06-30 $947
2009-03-31 $905
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.788B $2.567B
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $226.329B 27.30
Boston Scientific (BSX) United States $151.960B 38.05
Stryker (SYK) United States $141.576B 30.43
EssilorLuxottica (ESLOY) France $131.433B 0.00
Medtronic (MDT) Ireland $108.503B 15.84
Lonza Group Ag (LZAGY) Switzerland $51.360B 0.00
Haleon (HLN) United Kingdom $46.382B 26.36
ResMed (RMD) United States $34.859B 26.18
GE HealthCare Technologies (GEHC) United States $31.175B 15.16
Agilent Technologies (A) United States $30.637B 20.24
Terumo (TRUMY) Japan $28.678B 0.00
Koninklijke Philips (PHG) Netherlands $23.527B 16.80
Zimmer Biomet Holdings (ZBH) United States $20.336B 12.85
Insulet (PODD) United States $17.646B 75.46
Baxter (BAX) United States $15.890B 11.43
Smith & Nephew SNATS (SNN) United Kingdom $11.790B 0.00
Sunny Optical Technology (SNPTF) China $7.609B 0.00
Demant (WILYY) Denmark $7.600B 0.00
Lantheus Holdings (LNTH) United States $7.119B 17.50
Prestige Consumer Healthcare (PBH) United States $4.059B 19.37
Perrigo (PRGO) Ireland $3.496B 10.01
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.378B 28.78
Haemonetics (HAE) United States $3.214B 15.12
Envista Holdings (NVST) United States $2.745B 22.19
GN Store Nord (GNNDY) Denmark $2.260B 15.23
LeMaitre Vascular (LMAT) United States $2.092B 47.73
QuidelOrtho (QDEL) United States $1.928B 16.15
AtriCure (ATRC) United States $1.715B 0.00
Kestra Medical Technologies (KMTS) United States $1.258B 0.00
Green Thumb Industries (GTBIF) United States $1.250B 19.63
BioLife Solutions (BLFS) United States $1.174B 0.00
AdaptHealth (AHCO) United States $1.129B 10.87
Neogen (NEOG) United States $1.092B 13.97
InMode (INMD) Israel $1.003B 9.18
Phibro Animal Health (PAHC) United States $0.765B 11.73
Evolus (EOLS) United States $0.746B 0.00
Curaleaf Holdings (CURLF) Canada $0.596B 0.00
CeriBell (CBLL) United States $0.587B 0.00
Capricor Therapeutics (CAPR) United States $0.574B 0.00
Owens & Minor (OMI) United States $0.541B 4.61
Valneva SE (VALN) France $0.539B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.526B 0.00
Tilray Brands (TLRY) Canada $0.493B 0.00
Surmodics (SRDX) United States $0.442B 0.00
Omeros (OMER) United States $0.419B 0.00
Cresco Labs (CRLBF) United States $0.414B 0.00
SNDL (SNDL) Canada $0.389B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.357B 0.00
VAREX IMAGING (VREX) United States $0.346B 15.02
Verano Holdings (VRNOF) United States $0.307B 0.00
Sanara MedTech (SMTI) United States $0.286B 0.00
Viemed Healthcare (VMD) United States $0.275B 24.82
ZimVie (ZIMV) United States $0.264B 15.78
Aurora Cannabis (ACB) Canada $0.261B 46.40
Cerus (CERS) United States $0.260B 0.00
Canopy Growth (CGC) Canada $0.256B 0.00
OraSure Technologies (OSUR) United States $0.237B 0.00
Quanterix (QTRX) United States $0.235B 0.00
Sanuwave Health (SNWV) United States $0.220B 0.00
High Tide (HITI) Canada $0.196B 0.00
Biote (BTMD) United States $0.194B 4.43
TriSalus Life Sciences (TLSI) United States $0.185B 0.00
Utah Medical Products (UTMD) United States $0.172B 13.89
Brainsway (BWAY) Israel $0.168B 52.29
Organigram Global (OGI) Canada $0.144B 0.00
FitLife Brands (FTLF) United States $0.143B 17.99
Jin Medical (ZJYL) China $0.140B 0.00
Exagen (XGN) United States $0.123B 0.00
Agape ATP (ATPC) $0.121B 0.00
TerrAscend (TSNDF) Canada $0.108B 0.00
MacroGenics (MGNX) United States $0.101B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.095B 0.00
Quipt Home Medical (QIPT) United States $0.094B 0.00
Veru (VERU) United States $0.081B 0.00
Fonar (FONR) United States $0.078B 10.86
Cytosorbents (CTSO) United States $0.070B 0.00
InterCure (INCR) Israel $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.068B 0.00
Zynex (ZYXI) United States $0.067B 0.00
United Health Products (UEEC) United States $0.066B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Modular Medical (MODD) United States $0.041B 0.00
Rockwell Medical (RMTI) United States $0.038B 55.00
Safety Shot (SHOT) United States $0.037B 0.00
United-Guardian (UG) United States $0.036B 11.11
Apyx Medical (APYX) United States $0.036B 0.00
Nephros (NEPH) United States $0.021B 0.00
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.007B 0.00
Innovative Eyewear (LUCY) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Senestech (SNES) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00